» Articles » PMID: 33951659

Are Individuals with Substance Use Disorders at Higher Risk of SARS-CoV-2 Infection? Population-Based Registry Study in Northern Italy

Overview
Journal Eur Addict Res
Publisher Karger
Specialty Psychiatry
Date 2021 May 5
PMID 33951659
Citations 5
Authors
Affiliations
Soon will be listed here.
Abstract

Background And Aim: This study assesses whether individuals with substance use disorder are at greater risk of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection than people in the general population.

Methods: A population-based study was conducted including 3,780 individuals, diagnosed with alcohol or other drug dependence and cared for by the addiction service (AS) in the province of Reggio Emilia. Standardised incidence ratios (SIRs) and relative 95% confidence intervals (CIs) of being tested and of being SARS-CoV-2 positive in the population of interest compared with those in the general population of Reggio Emilia were calculated.

Results: Both individuals with alcohol and those with other drug use disorders had a lower risk of being SARS-CoV-2 positive (SIR = 0.69; 95% CI 0.32-1.30, SIR = 0.56; 95% CI 0.24-1.10, respectively), despite higher rates of being tested than the general population (SIR = 1.48; 95% CI 1.14-1.89, SIR = 1.51; 95% CI 1.20-1.86, respectively). Among HIV-negative persons, 12.5% were positive to SARS-CoV-2, while none was positive among HIV-positive persons. HCV-infected AS clients had a higher risk of both being tested for SARS-CoV-2 (SIR = 1.99; 95% CI 1.26-2.98) and of resulting positive (SIR = 1.53; 95% CI 0.50-3.58).

Conclusions: Individuals with alcohol and/or other drug use disorders are at higher risk of being tested for SARS-CoV-2 infection but at lower risk of resulting positive than the general population. Further research is warranted in order to support our findings and to address plausible factors underpinning such associations.

Citing Articles

Substance abuse among new patients attending main government hospitals in Malaysia from 2018-2021: A comparison between before and during COVID-19 pandemic.

Muhamad N, Chemi N, Maamor N, Rosli I, Leman F, Mohamad Isa M PLoS One. 2024; 19(10):e0309422.

PMID: 39446726 PMC: 11500913. DOI: 10.1371/journal.pone.0309422.


Seroprevalence of SARS-CoV-2 and humoral immune responses to COVID-19 mRNA vaccines among people who use drugs - in the light of tailored mitigating strategies.

Wusthoff L, Lund-Johansen F, Henriksen K, Wildendahl G, Jacobsen J, Gomes L Harm Reduct J. 2024; 21(1):120.

PMID: 38890611 PMC: 11186241. DOI: 10.1186/s12954-024-01023-9.


Incidence of SARS-CoV-2 and all-cause mortality in persons with co-occurring substance use disorder and mental illness during the pandemic: a Norwegian cohort study.

Leonhardt M, Bramness J, Lien L Soc Psychiatry Psychiatr Epidemiol. 2023; 59(8):1379-1387.

PMID: 38015236 DOI: 10.1007/s00127-023-02599-6.


Unintended Consequences of COVID-19 Non-Pharmaceutical Interventions (NPIs) for Population Health and Health Inequalities.

OhAiseadha C, Quinn G, Connolly R, Wilson A, Connolly M, Soon W Int J Environ Res Public Health. 2023; 20(7).

PMID: 37047846 PMC: 10094123. DOI: 10.3390/ijerph20075223.


COVID-19 Lockdown and Consumption Patterns among Substance Use Disorder Outpatients: A Multicentre Study.

Grau-Lopez L, Daigre C, Palma-Alvarez R, Sorribes-Puertas M, Serrano-Perez P, Quesada-Franco M Eur Addict Res. 2022; 28(4):243-254.

PMID: 35038702 PMC: 8805052. DOI: 10.1159/000521425.

References
1.
Rahman A, Sathi N . Risk factors of the severity of COVID-19: A meta-analysis. Int J Clin Pract. 2020; 75(7):e13916. DOI: 10.1111/ijcp.13916. View

2.
Vizcarra P, Perez-Elias M, Quereda C, Moreno A, Vivancos M, Dronda F . Description of COVID-19 in HIV-infected individuals: a single-centre, prospective cohort. Lancet HIV. 2020; 7(8):e554-e564. PMC: 7255735. DOI: 10.1016/S2352-3018(20)30164-8. View

3.
Marsden J, Darke S, Hall W, Hickman M, Holmes J, Humphreys K . Mitigating and learning from the impact of COVID-19 infection on addictive disorders. Addiction. 2020; 115(6):1007-1010. PMC: 9364227. DOI: 10.1111/add.15080. View

4.
Testino G . Are Patients With Alcohol Use Disorders at Increased Risk for Covid-19 Infection?. Alcohol Alcohol. 2020; 55(4):344-346. PMC: 7239257. DOI: 10.1093/alcalc/agaa037. View

5.
Volkow N . Collision of the COVID-19 and Addiction Epidemics. Ann Intern Med. 2020; 173(1):61-62. PMC: 7138334. DOI: 10.7326/M20-1212. View